Insights on the Oncology Therapeutic Drug Market Report & Forecast to 2028 - by Players, Types, Applications and Region
QYResearch released a latest market research report on the Global and United States Oncology Therapeutic Drug market, which is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the Global Oncology Therapeutic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Scope of the Oncology Therapeutic Drug Market Report
This report focuses on global and United States Oncology Therapeutic Drug market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Oncology Therapeutic Drug market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Chemotherapy accounting for % of the Oncology Therapeutic Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Breast Cancer was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
For more information about this report, visit
Key Questions Answered in This Report
How has the Global and United States Oncology Therapeutic Drug performed so far and how will it perform in the coming years?
What are the key regional markets?
What is the breakup of the market based on the Oncology Therapeutic Drug type?
What is the breakup of the market based on the application?
What is the breakup of the market size based on the region?
What is the breakup of the market based on the region Level & country Level?
Who are the key players of the Global and United States Oncology Therapeutic Drug?
Segments Covered in the Report
Segment by Type
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy
Others
Segment by Application
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory and Lung Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
AbbVie
Amgen
Astellas Pharma
AstraZeneca
Bayer
Biogen
Bristol Myers Squibb
Celgene
Eisai
Eli Lilly and Company
Gilead Sciences
Ipsen
Johnson and Johnson
Merck
Novartis
Otsuka Pharmaceutical
Pfizer
F. Hoffmann-La Roche
Sanofi
Takeda Pharmaceutical
Teva Pharmaceutical Industries
Key Topics Covered
1 Study Coverage
2 Oncology Therapeutic Drug by Platform
3 Oncology Therapeutic Drug by Application
4 Global Oncology Therapeutic Drug Competitor Landscape by Company
5 Global Oncology Therapeutic Drug Market Size by Region
5.1 Global Oncology Therapeutic Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Oncology Therapeutic Drug Market Size by Region (2017-2028)
5.2.1 Global Oncology Therapeutic Drug Market Size by Region: 2017-2022
5.2.2 Global Oncology Therapeutic Drug Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Oncology Therapeutic Drug Market Size YoY Growth 2017-2028
6.1.2 North America Oncology Therapeutic Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Oncology Therapeutic Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Oncology Therapeutic Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Oncology Therapeutic Drug Market Size YoY Growth 2017-2028
6.3.2 Europe Oncology Therapeutic Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Oncology Therapeutic Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America Oncology Therapeutic Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Oncology Therapeutic Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Oncology Therapeutic Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Corporation Information
7.1.2 AbbVie Description and Business Overview
7.1.3 AbbVie Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.1.4 AbbVie Oncology Therapeutic Drug Products Offered
7.1.5 AbbVie Recent Development
7.2 Amgen
7.2.1 Amgen Corporation Information
7.2.2 Amgen Description and Business Overview
7.2.3 Amgen Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Amgen Oncology Therapeutic Drug Products Offered
7.2.5 Amgen Recent Development
7.3 Astellas Pharma
7.3.1 Astellas Pharma Corporation Information
7.3.2 Astellas Pharma Description and Business Overview
7.3.3 Astellas Pharma Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Astellas Pharma Oncology Therapeutic Drug Products Offered
7.3.5 Astellas Pharma Recent Development
7.4 AstraZeneca
7.4.1 AstraZeneca Corporation Information
7.4.2 AstraZeneca Description and Business Overview
7.4.3 AstraZeneca Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.4.4 AstraZeneca Oncology Therapeutic Drug Products Offered
7.4.5 AstraZeneca Recent Development
7.5 Bayer
7.5.1 Bayer Corporation Information
7.5.2 Bayer Description and Business Overview
7.5.3 Bayer Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Bayer Oncology Therapeutic Drug Products Offered
7.5.5 Bayer Recent Development
7.6 Biogen
7.6.1 Biogen Corporation Information
7.6.2 Biogen Description and Business Overview
7.6.3 Biogen Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Biogen Oncology Therapeutic Drug Products Offered
7.6.5 Biogen Recent Development
7.7 Bristol Myers Squibb
7.7.1 Bristol Myers Squibb Corporation Information
7.7.2 Bristol Myers Squibb Description and Business Overview
7.7.3 Bristol Myers Squibb Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Bristol Myers Squibb Oncology Therapeutic Drug Products Offered
7.7.5 Bristol Myers Squibb Recent Development
7.8 Celgene
7.8.1 Celgene Corporation Information
7.8.2 Celgene Description and Business Overview
7.8.3 Celgene Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Celgene Oncology Therapeutic Drug Products Offered
7.8.5 Celgene Recent Development
7.9 Eisai
7.9.1 Eisai Corporation Information
7.9.2 Eisai Description and Business Overview
7.9.3 Eisai Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Eisai Oncology Therapeutic Drug Products Offered
7.9.5 Eisai Recent Development
7.10 Eli Lilly and Company
7.10.1 Eli Lilly and Company Corporation Information
7.10.2 Eli Lilly and Company Description and Business Overview
7.10.3 Eli Lilly and Company Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Eli Lilly and Company Oncology Therapeutic Drug Products Offered
7.10.5 Eli Lilly and Company Recent Development
7.11 Gilead Sciences
7.11.1 Gilead Sciences Corporation Information
7.11.2 Gilead Sciences Description and Business Overview
7.11.3 Gilead Sciences Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Gilead Sciences Oncology Therapeutic Drug Products Offered
7.11.5 Gilead Sciences Recent Development
7.12 Ipsen
7.12.1 Ipsen Corporation Information
7.12.2 Ipsen Description and Business Overview
7.12.3 Ipsen Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Ipsen Products Offered
7.12.5 Ipsen Recent Development
7.13 Johnson and Johnson
7.13.1 Johnson and Johnson Corporation Information
7.13.2 Johnson and Johnson Description and Business Overview
7.13.3 Johnson and Johnson Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Johnson and Johnson Products Offered
7.13.5 Johnson and Johnson Recent Development
7.14 Merck
7.14.1 Merck Corporation Information
7.14.2 Merck Description and Business Overview
7.14.3 Merck Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Merck Products Offered
7.14.5 Merck Recent Development
7.15 Novartis
7.15.1 Novartis Corporation Information
7.15.2 Novartis Description and Business Overview
7.15.3 Novartis Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Novartis Products Offered
7.15.5 Novartis Recent Development
7.16 Otsuka Pharmaceutical
7.16.1 Otsuka Pharmaceutical Corporation Information
7.16.2 Otsuka Pharmaceutical Description and Business Overview
7.16.3 Otsuka Pharmaceutical Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Otsuka Pharmaceutical Products Offered
7.16.5 Otsuka Pharmaceutical Recent Development
7.17 Pfizer
7.17.1 Pfizer Corporation Information
7.17.2 Pfizer Description and Business Overview
7.17.3 Pfizer Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Pfizer Products Offered
7.17.5 Pfizer Recent Development
7.18 F. Hoffmann-La Roche
7.18.1 F. Hoffmann-La Roche Corporation Information
7.18.2 F. Hoffmann-La Roche Description and Business Overview
7.18.3 F. Hoffmann-La Roche Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.18.4 F. Hoffmann-La Roche Products Offered
7.18.5 F. Hoffmann-La Roche Recent Development
7.19 Sanofi
7.19.1 Sanofi Corporation Information
7.19.2 Sanofi Description and Business Overview
7.19.3 Sanofi Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Sanofi Products Offered
7.19.5 Sanofi Recent Development
7.20 Takeda Pharmaceutical
7.20.1 Takeda Pharmaceutical Corporation Information
7.20.2 Takeda Pharmaceutical Description and Business Overview
7.20.3 Takeda Pharmaceutical Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.20.4 Takeda Pharmaceutical Products Offered
7.20.5 Takeda Pharmaceutical Recent Development
7.21 Teva Pharmaceutical Industries
7.21.1 Teva Pharmaceutical Industries Corporation Information
7.21.2 Teva Pharmaceutical Industries Description and Business Overview
7.21.3 Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
7.21.4 Teva Pharmaceutical Industries Products Offered
7.21.5 Teva Pharmaceutical Industries Recent Development
8 Industry Chain and Sales Channels Analysis
For more information about this report, visit
Any questions or requirements, please do not hesitate to contact us.
About Us:
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years’ experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let’s work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com